New 13D18
New 13G68
Stated intents0
The week of 2025-12-08, 18 holders filed a new Schedule 13D and 68 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-12-08 | Envoy Medical, Inc. | Glen A. Taylor | 44.2% | SCHEDULE 13D |
| 2025-12-09 | InterCure Ltd. | Alexander Rabinovich | 29.4% | SCHEDULE 13D |
| 2025-12-12 | Westin Acquisition Corp | Westin Investment Co. Ltd. | 27.9% | SCHEDULE 13D |
| 2025-12-11 | W. R. Berkley Corporation | WR Berkley & Others LLC | 25.14% | SCHEDULE 13D |
| 2025-12-12 | 374Water Inc. | Nagar Yaacov | 19% | SCHEDULE 13D |
| 2025-12-10 | Psyence Biomedical Ltd. | KAOS Capital Ltd. | 16.77% | SCHEDULE 13D |
| 2025-12-08 | Powerdyne International, Inc. | Read Arthur M II | 15.4% | SCHEDULE 13D |
| 2025-12-11 | W. R. Berkley Corporation | Mitsui Sumitomo Insurance Co., Ltd. | 12.8% | SCHEDULE 13D |
| 2025-12-11 | Silvia, Inc. | Anthony Pompliano | 12.4% | SCHEDULE 13D |
| 2025-12-09 | Pacific Coast Oil Trust | Eriksen Capital Management LLC | 11.7% | SCHEDULE 13D |
| 2025-12-12 | Chicago Rivet & Machine Co | Morrissey John A | 10.1% | SCHEDULE 13D |
| 2025-12-10 | Hudson Technologies Inc | Hartree Partners, LP | 8.7% | SCHEDULE 13D |
| 2025-12-12 | Freenome, Inc. | RA Capital Management, L.P. | 8.4% | SCHEDULE 13D |
| 2025-12-08 | Yatra Online, Inc. | Dhruv Shringi | 7.17% | SCHEDULE 13D |
| 2025-12-08 | Powerdyne International, Inc. | Madison Linda | 6.4% | SCHEDULE 13D |
| 2025-12-08 | Provectus Biopharmaceuticals, Inc. | Dominic Rodrigues | 5.67% | SCHEDULE 13D |
| 2025-12-08 | Carver Bancorp Inc | Detyga LLC | 5.3% | SCHEDULE 13D |
| 2025-12-09 | Clough Global Equity Fund | Saba Capital Management, L.P. | 5.06% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-12-08 | CTW Cayman | Ryuichi Sasaki | 96.15% | SCHEDULE 13G |
| 2025-12-11 | Pgim Etf Trust | Intrua Financial, LLC | 32% | SCHEDULE 13G |
| 2025-12-10 | First Trust Exchange-Traded Fund Iv | Strategic Planning Group, LLC | 25.3% | SCHEDULE 13G |
| 2025-12-11 | Orla Mining Ltd | V. Prem Watsa | 19.8% | SCHEDULE 13G |
| 2025-12-12 | Central Bancompany, Inc. | The Central Trust Bank | 19.49% | SCHEDULE 13G |
| 2025-12-12 | Knorex Ltd. | Franklin Capital Enterprise Ltd | 17.1% | SCHEDULE 13G |
| 2025-12-12 | Fusemachines Inc. | Consilium Frontier Equity Fund LP | 15.9% | SCHEDULE 13G |
| 2025-12-12 | Fusemachines Inc. | Consilium Extended Opportunities Fund LP | 14.4% | SCHEDULE 13G |
| 2025-12-08 | Netcapital Inc. | GlobexUS Holdings, Corp. | 10.17% | SCHEDULE 13G |
| 2025-12-08 | Equillium Inc. | Janus Henderson Group Plc | 9.99% | SCHEDULE 13G |
| 2025-12-08 | Immunic, Inc. | Janus Henderson Group Plc | 9.99% | SCHEDULE 13G |
| 2025-12-08 | Ovid Therapeutics Inc. | Janus Henderson Group Plc | 9.99% | SCHEDULE 13G |
| 2025-12-08 | Palatin Technologies Inc | Janus Henderson Group Plc | 9.99% | SCHEDULE 13G |
| 2025-12-08 | Palisade Bio, Inc. | Janus Henderson Group Plc | 9.99% | SCHEDULE 13G |
| 2025-12-08 | Pasithea Therapeutics Corp. | Janus Henderson Group Plc | 9.99% | SCHEDULE 13G |
| 2025-12-08 | Tenax Therapeutics, Inc. | Janus Henderson Group Plc | 9.99% | SCHEDULE 13G |
| 2025-12-11 | Top Wealth Group Holding Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2025-12-11 | Xilio Therapeutics, Inc. | Coastlands Capital LP | 9.99% | SCHEDULE 13G |
| 2025-12-12 | Polyrizon Ltd. | Eli Zamir | 9.99% | SCHEDULE 13G |
| 2025-12-12 | Polyrizon Ltd. | L.I.A. Pure Capital Ltd. | 9.99% | SCHEDULE 13G |
| 2025-12-10 | Top Wealth Group Holding Ltd | Bigger Capital Fund L P | 9.97% | SCHEDULE 13G |
| 2025-12-08 | Cantor Equity Partners I, Inc. | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2025-12-08 | Velos Acquisition I Corp. f/k/a M3-Brigade Acquisition V Corp. | Anson Funds Management LP | 9.9% | SCHEDULE 13G |
| 2025-12-11 | Top Wealth Group Holding Ltd | Avondale Capital, LLC | 9.9% | SCHEDULE 13G |
| 2025-12-11 | CXApp Inc. | Avondale Capital, LLC | 9.9% | SCHEDULE 13G |
| 2025-12-12 | Perpetuals.com Ltd | Aldersgate Capital Partners Ltd. | 9.9% | SCHEDULE 13G |
| 2025-12-12 | Antelope Enterprise Holdings Ltd | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-12-12 | Arrive AI Inc. | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-12-11 | Jaguar Health, Inc. | Iliad Research & Trading, L.P. | 9.8% | SCHEDULE 13G |
| 2025-12-08 | Dbv Technologies S.A. | Janus Henderson Group Plc | 9.5% | SCHEDULE 13G |
| 2025-12-11 | SciSparc Ltd. | Ronen Fatal | 8.76% | SCHEDULE 13G |
| 2025-12-11 | SciSparc Ltd. | Eli Zamir | 8.76% | SCHEDULE 13G |
| 2025-12-12 | Silvia, Inc. | Jane Street Group, LLC | 8.6% | SCHEDULE 13G |
| 2025-12-11 | Quoin Pharmaceuticals Ltd. | Resolute Capital Asset Partners LLC | 8.5% | SCHEDULE 13G |
| 2025-12-08 | Assembly Biosciences, Inc. | Janus Henderson Group Plc | 8.2% | SCHEDULE 13G |
| 2025-12-09 | Chenghe Acquisition III Co. | Picton Mahoney Asset Management | 7.66% | SCHEDULE 13G |
| 2025-12-08 | Lantronix Inc | TL Stiftung | 7.6% | SCHEDULE 13G |
| 2025-12-11 | Proshares Trust | Samuel Patton Black IV | 7.6% | SCHEDULE 13G |
| 2025-12-11 | DENNY'S Corp | Glazer Capital, LLC | 7.38% | SCHEDULE 13G |
| 2025-12-10 | Cartesian Growth Corp III | Picton Mahoney Asset Management | 7.25% | SCHEDULE 13G |
| 2025-12-08 | SaverOne 2014 Ltd. | Liu Yi Ming | 7% | SCHEDULE 13G |
| 2025-12-10 | Belite Bio, Inc | Darwin Global Management, Ltd. | 7% | SCHEDULE 13G |
| 2025-12-12 | Cool Company Ltd. | Silver Point Capital, L.P. | 7% | SCHEDULE 13G |
| 2025-12-08 | Blue Water Acquisition Corp. III | Harraden Circle Investments, LLC | 6.63% | SCHEDULE 13G |
| 2025-12-10 | New America Acquisition I Corp. | Harraden Circle Investments, LLC | 6.62% | SCHEDULE 13G |
| 2025-12-11 | New America Acquisition I Corp. | Washington Muse Investments SPC for and on behalf of Heraclitus SP | 6.51% | SCHEDULE 13G |
| 2025-12-08 | Build-a-Bear Workshop, Inc | Divisadero Street Capital Management, LP | 6.4% | SCHEDULE 13G |
| 2025-12-09 | Integral Ad Science Holding Corp. | Glazer Capital, LLC | 6.32% | SCHEDULE 13G |
| 2025-12-10 | Australian Oilseeds Holdings Ltd | Arena Investors LP | 6.3% | SCHEDULE 13G |
| 2025-12-11 | Proshares Trust | Christopher William Black | 6.2% | SCHEDULE 13G |
| 2025-12-10 | Hawaiian Electric Industries Inc | Arena Holdings Management LLC | 6.1% | SCHEDULE 13G |
| 2025-12-11 | Crescent Biopharma, Inc. | ForGrowth III PA B.V. | 6.1% | SCHEDULE 13G |
| 2025-12-08 | Ocugen, Inc. | Janus Henderson Group Plc | 6% | SCHEDULE 13G |
| 2025-12-08 | Bitcoin Infrastructure Acquisition Corp Ltd | Tenor Capital Management Company, L.P. | 6% | SCHEDULE 13G |
| 2025-12-08 | RLJ Lodging Trust | He Zhengxu | 5.9% | SCHEDULE 13G |
| 2025-12-09 | SilverBox Corp V | Tenor Capital Management Company, L.P. | 5.9% | SCHEDULE 13G |
| 2025-12-08 | Ocular Therapeutix, Inc | Summer Road LLC | 5.7% | SCHEDULE 13G |
| 2025-12-10 | Astria Therapeutics, Inc. | Glazer Capital, LLC | 5.53% | SCHEDULE 13G |
| 2025-12-10 | Core Scientific, Inc. | Citadel Securities GP LLC | 5.5% | SCHEDULE 13G |
| 2025-12-08 | TeraWulf Inc. | Citadel Securities GP LLC | 5.4% | SCHEDULE 13G |
| 2025-12-10 | Virtus Convertible & Income Fund II | Advisors Asset Management, Inc. | 5.29% | SCHEDULE 13G |
| 2025-12-08 | Rithm Property Trust Inc. | Bay Pond Partners, L.P. | 5.1% | SCHEDULE 13G |
| 2025-12-08 | General Purpose Acquisition Corp. | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2025-12-08 | Solaris Energy Infrastructure, Inc. | Jane Street Group, LLC | 5.1% | SCHEDULE 13G |
| 2025-12-08 | Maui Land & Pineapple Company, Inc. | Valueworks LLC | 5.03% | SCHEDULE 13G |
| 2025-12-08 | Biomea Fusion, Inc. | Janus Henderson Group Plc | 5% | SCHEDULE 13G |
| 2025-12-09 | Neogenomics, Inc. | Millennium Management LLC | 5% | SCHEDULE 13G |
| 2025-12-09 | Sintx Technologies Inc | Gregg Richard Honigblum | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)87 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.